Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Carmichael Roberts
AddedMar 31, 2024
UpdatedMay 31, 2026
Carmichael Roberts

Carmichael Roberts

Co-Founder, Material Impact

CrunchbaseLinkedIn

Carmichael Roberts's Career

Material Impact
Material Impact

Boston, MA, US

Co-Founder
Lyra Therapeutics
Lyra Therapeutics

Watertown, MA, US

Board Member· Board
Aushon Biosystems
Aushon Biosystems

Billerica, MA, US

Board Member· Board
CubicPV
CubicPV

Bedford, MA, US

Board Member· Board
Nano Terra
Nano Terra

Cambridge, MA, US

Board Member· Board
Foro Energy
Foro Energy

Littleton, CO, US

Board Member· Board
Soft Robotics
Soft Robotics

Cambridge, MA, US

Board Member· Board
Arsenal Medical
Arsenal Medical

Watertown, MA, US

Co-Founder
MC10
MC10

Cambridge, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Carmichael Roberts's Career

Material Impact
Material Impact
Investment FirmInvestment Firm182016Boston, MA, US
Co-Founder

Recent news

How a New Jersey startup found an electrifying way to slash copper costsTechCrunch · 2025
Amperesand raises $12.5M seed round to remake the humble 140-year-oldntransformerTechCrunch · 2024
Lyra Therapeutics
Lyra Therapeutics
Public$264.1M662014Watertown, MA, US
Board Member· Board

Leadership at Lyra Therapeutics

Nancy SnydermanNancy SnydermanBoard Member
Paulina HillPaulina HillBoard Member
Bob LangerBob LangerBoard Member
Guido NeelsGuido NeelsBoard Member
Konstantin PoukalovKonstantin PoukalovBoard Member
Maria BerkmanMaria BerkmanBoard Member

Similar to Lyra Therapeutics

LyndraLyndraWatertown, MA, USPharmaceuticals, Therapiesest. 2015LyndraWatertown, MA, US · est. 2015

US-based Lyndra Therapeutics develops therapies for Alzheimer's, HIV, opioid use disorder, and schizophrenia.

Series E · $284.6M161
Lyric PharmaceuticalsLyric PharmaceuticalsSan Francisco, CA, USTherapeuticsest. 2013Lyric PharmaceuticalsSan Francisco, CA, US · est. 2013

Lyric, a clinical-stage company, innovates gastrointestinal therapeutics for unmet hospital needs.

Series A · $20.4M6
Cara TherapeuticsCara TherapeuticsStamford, CT, USDrugs, Therapeuticsest. 2004Cara TherapeuticsStamford, CT, US · est. 2004

Cara Therapeutics, a Connecticut-based medical firm, develops novel drugs for pain and inflammation treatment.

Public · $517.2M106
Cyrano TherapeuticsCyrano TherapeuticsDelray Beach, FL, USPharmaceuticals, Therapeuticsest. 2014Cyrano TherapeuticsDelray Beach, FL, US · est. 2014

Cyrano Therapeutics: Innovating intranasal solutions to restore taste and smell functions.

Series B · $21.8M7
Aushon Biosystems
Aushon Biosystems
Acquired$37.4M02003Billerica, MA, US
Board Member· Board

Leadership at Aushon Biosystems

Bruns GraysonBruns GraysonBoard Member
Bill GearyBill GearyBoard Member
Stanley LapidusStanley LapidusBoard Member
Jim IulianoJim IulianoBoard Member
Tom Mac MahonTom Mac MahonBoard Member
Peter HonkanenPeter HonkanenBoard Member

Similar to Aushon Biosystems

MetabolonMetabolonDurham, NC, USBiomarkers, Diagnosticsest. 2000MetabolonDurham, NC, US · est. 2000

Metabolon, based in Durham, US, leads in metabolomics for biomarker discovery, diagnostics & precision medicine.

Public · $199.7M302
BiophysicalBiophysicalAustin, TX, USHealth Assessmentsest. 2004BiophysicalAustin, TX, US · est. 2004

Biophysical Corporation: Managing and marketing biomarker-based health assessments.

Series A · $8.4M75
QuanterixQuanterixBillerica, MA, USBiomarker Analysisest. 2007QuanterixBillerica, MA, US · est. 2007

Quanterix: Advancing precision health science through digitized biomarker analysis in Lexington, US.

Public · $533.3M125
Solus BiosystemsSolus BiosystemsPalo Alto, CA, USProtein Analysisest. 2001Solus BiosystemsPalo Alto, CA, US · est. 2001

Solus Biosystems develops advanced platforms for measuring protein conformation changes, enhancing pharmaceutical applications.

Pre-Seed · $800k5
CubicPV
CubicPV
Series C$58M822007Bedford, MA, US
Board Member· Board

Leadership at CubicPV

Frank van MierloFrank van MierloBoard Member
Reidar LangmoReidar LangmoBoard Member
Yasheng HuangYasheng HuangBoard Member
Bruce SohnBruce SohnBoard Member
Michael IrwinMichael IrwinFounder

Similar to CubicPV

Tandem PVTandem PVFremont, CA, USSolar Panelsest. 2016Tandem PVFremont, CA, US · est. 2016

Innovative provider of mechanically-stacked perovskite+silicon tandem solar panels.

Series A · $66.6M50
Integrating PVIntegrating PVSunnyvale, CA, USPhotovoltaics, Solarest. 2007Integrating PVSunnyvale, CA, US · est. 2007

Integrated Photovoltaics, a leading solar tech firm, innovates next-gen photovoltaic solutions in Sunnyvale, CA.

Series A · $8.5M75
PureSolarPureSolarTumwater, WA, USSolar Panelsest. 2010PureSolarTumwater, WA, US · est. 2010

PureSolar: A leading manufacturer of advanced photovoltaic cells for clean, renewable energy.

Pre-Seed · $65k12
SempriusSempriusDurham, NC, USSolar Modulesest. 2005SempriusDurham, NC, US · est. 2005

Semprius: Innovating solar power generation with advanced photovoltaic modules.

Angel · $65.3M32
Nano Terra
Nano Terra
Series A$26.4M302005Cambridge, MA, US
Board Member· Board

Leadership at Nano Terra

Myer BerlowMyer BerlowBoard Member
Ueli MorantUeli MorantFounder
Sindi HayatSindi HayatBoard Member
Foro Energy
Foro Energy
Series A$66.2M362009Littleton, CO, US
Board Member· Board

Leadership at Foro Energy

Tom BaruchTom BaruchBoard Member
Jeffrey HarrisJeffrey HarrisBoard Member
Paul DeutchPaul DeutchBoard Member
Joel MoxleyJoel MoxleyFounder
John YearwoodJohn YearwoodBoard Member
Joel MoxleyJoel MoxleyBoard Member

Similar to Foro Energy

Forum Energy TechnologiesForum Energy TechnologiesHouston, TX, USDrillingest. 2005Forum Energy TechnologiesHouston, TX, US · est. 2005

Forum Energy Technologies: Providing innovative products and services for drilling, intervention, and subsea sectors in the energy industry.

Public1.5k
Forum TechnologiesForum TechnologiesHouston, TX, USData Management, Technologiesest. 1999Forum TechnologiesHouston, TX, US · est. 1999

Forum Energy Technologies: Houston-based manufacturer of energy industry technologies and data management services.

Public · $3M8
Forge EnergyForge EnergySan Antonio, TX, USOilest. 2011Forge EnergySan Antonio, TX, US · est. 2011

Forge Energy LLC: A leading US producer and supplier of oil, gas, and other petroleum products.

Private Equity · $400M34
Focused EnergyFocused EnergyAustin, TX, USClean Energyest. 2021Focused EnergyAustin, TX, US · est. 2021

Focused Energy: A laser fusion startup innovating clean, alternative energy solutions.

Series A · $79M48
Soft Robotics
Soft Robotics
Series C$86M1342012Cambridge, MA, US
Board Member· Board

Leadership at Soft Robotics

Jeffrey A BeckJeffrey A BeckBoard Member
Adam SharkawyAdam SharkawyBoard Member
Kevin DunlapKevin DunlapBoard Member
George WhitesidesGeorge WhitesidesBoard Member
Arsenal Medical
Arsenal Medical
Series A$71.4M422005Watertown, MA, US
Co-Founder

Leadership at Arsenal Medical

Upma Sharma, PhDUpma Sharma, PhDCEO

Similar to Arsenal Medical

Audax MedicalAudax MedicalConcord, MA, USMedical Devices, Orthobiologicsest. 2009Audax MedicalConcord, MA, US · est. 2009

US-based Audax Medical develops orthopedic biomaterials and medical instruments for bone and tissue regeneration, specializing in orthobiologics.

Seed · $687.5k2
Adient MedicalAdient MedicalPearland, TX, USMedical Devicesest. 2012Adient MedicalPearland, TX, US · est. 2012

Adient, based in Pearland, US, is a leading provider of absorbable medical implant devices.

Series B · $17.5M11
Ariste MedicalAriste MedicalMemphis, TN, USSurgical Implantsest. 2015Ariste MedicalMemphis, TN, US · est. 2015

Ariste develops drug-eluting surgical implants to prevent device failure.

Angel · $6.2M5
EmboMedicsEmboMedicsMaple Grove, MN, USMedical Devicesest. 2012EmboMedicsMaple Grove, MN, US · est. 2012

EmboMedics: Developing and commercializing resorbable, drug-loaded embolization devices since 2012.

Pre-Seed · $7.6M5
MC10
MC10
Series A$97.4M382008Cambridge, MA, US
Board Member· Board

Leadership at MC10

Roozbeh GhaffariRoozbeh GhaffariCo-Founder
Gilman CallsenGilman CallsenCo-Founder
Paul H. KlingensteinPaul H. KlingensteinBoard Member
Adam FineAdam FineBoard Member
Jiong MaJiong MaBoard Member
John RogersJohn RogersCo-Founder

Carmichael Roberts's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Carmichael Roberts

Jeffrey LeventhalJeffrey LeventhalFounder · S12FYuval ShacharYuval ShacharBoard Member · Team8Rob CarlsonRob CarlsonFounder · Bioeconomy CapitalJames HoganJames HoganBoard Member · Vista VenturesMichael GreeleyMichael GreeleyCo-Founder · Flare Capital PartnersJohn RiceJohn RiceCo-Founder · Triathlon Medical Venture Partners